SEC Filings - Aura Biosciences

Filing date	Form	Description	Filing Group	View
11/03/2023	144	Filed by "insiders" prior intended sale of restricted stock. Non-EDGAR filing	Other	View HTML 0000950170-23-058843.pdf 0000950170-23-058843.rtf 0000950170-23-058843.xls
11/03/2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000950170-23-058900.pdf 0000950170-23-058900.rtf 0000950170-23-058900.xls
11/01/2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000950170-23-057640.pdf 0000950170-23-057640.rtf 0000950170-23-057640.xls
11/01/2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000950170-23-057643.pdf 0000950170-23-057643.rtf 0000950170-23-057643.xls
10/23/2023	3	Initial filing by director officer or owner of more than ten percent	3,4,5	View HTML 0000950170-23-054690.pdf 0000950170-23-054690.rtf 0000950170-23-054690.xls
10/05/2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000950170-23-052244.pdf 0000950170-23-052244.rtf 0000950170-23-052244.xls
10/02/2023	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0001193125-23-249055.pdf 0001193125-23-249055.rtf 0001193125-23-249055.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
08/09/2023	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0000950170-23-040136.pdf 0000950170-23-040136.rtf 0000950170-23-040136.xls EX-101.LAB - XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
08/09/2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	View HTML 0000950170-23-040138.pdf 0000950170-23-040138.rtf 0000950170-23-040138.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
06/09/2023	4	Statement of changes in beneficial ownership of securities	3,4,5	View HTML 0000899243-23-015205.pdf 0000899243-23-015205.rtf 0000899243-23-015205.xls

Data provided by Kaleidoscope.